Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.
Br J Cancer 104(9):1418-25 (2011) PMID 21468050 PMCID PMC3101927
To date, no good marker for screening or disease monitoring of endometrial cancer (EC) is available. The aims of this study were to investigate HE4 gene, protein expression and serum HE4 (sHE4) levels in a panel of ECs and normal endometria (NEs) and to correlate sHE4 with patient clinicopathological characteristics and prognosis.
DOI: 10.1038/bjc.2011.109
Version: za2963e q8zad q8zb4 q8zc9 q8zda q8ze9 q8zf1 q8zg0